Related references
Note: Only part of the references are listed.Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort
Silvia Paddock et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Understanding the placebo effect: Contributions from neuroimaging
Sarah C. Lidstone et al.
MOLECULAR IMAGING AND BIOLOGY (2007)
Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder
B. S. Pickard et al.
MOLECULAR PSYCHIATRY (2006)
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment
FJ McMahon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders
RA Shih et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2004)
Clinical and health services relationships between major depression, depressive symptoms, and general medical illness
WJ Katon
BIOLOGICAL PSYCHIATRY (2003)
Placebo response and antidepressant clinical trial outcome
A Khan et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2003)
Share Paper
